Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
(38)
•••
Turtle4
X
View Profile
View Bullboard History
Comment by
Turtle4
on Sep 19, 2023 3:02am
RE:Activist shareholder needed
What's the point? There is no other potential CEO. And sirona cannot afford to look for a new one. This only makes sense when sirona is operating in a reasonably stable manner and has freedom of
...more
(2138)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Sep 18, 2023 4:29pm
Activist shareholder needed
https://www.accesswire.com/785118/concerned-shareholder-grant-sawiak-announces-that-he-has-received-proxies-representing-over-75-million-shares-or-approximately-40-of-the-shares-eligible-to-vote-at
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(38)
•••
Turtle4
X
View Profile
View Bullboard History
Comment by
Turtle4
on Sep 18, 2023 1:32pm
RE:RE:ANTIVIRAL
They wait for a good news to hide the bad antiviral news
(2138)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Sep 18, 2023 12:32pm
RE:ANTIVIRAL
more interested in when co. starts making money and not spending money
(33)
•••
SleepyHoward
X
View Profile
View Bullboard History
Post by
SleepyHoward
on Sep 18, 2023 12:00pm
ANTIVIRAL
Waiting for the antiviral results from augusr
(2138)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Sep 13, 2023 11:51am
Anti-aging patent application
It's been over 1 year since application was published and patent office still has not commented on it. https://patentcenter.uspto.gov/applications/17627347/ifw/docs?application=
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Sep 13, 2023 12:45am
RE:Antiviral
Once again management has failed to communicate with the market in terms of expectations. The results might have been received according to plan end of August. We don@t know.@ The failure though is
...more
(1167)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Sep 12, 2023 7:02pm
RE:RE:Antiviral
End of August is now a year away! That sounds about usual.
(33)
•••
SleepyHoward
X
View Profile
View Bullboard History
Comment by
SleepyHoward
on Sep 12, 2023 4:21pm
RE:RE:Antiviral
Never trust this management
(38)
•••
Turtle4
X
View Profile
View Bullboard History
Comment by
Turtle4
on Sep 12, 2023 1:38pm
RE:Antiviral
End of August, as claimed by management in the Q&A. Or in other words "soon"
(33)
•••
SleepyHoward
X
View Profile
View Bullboard History
Post by
SleepyHoward
on Sep 12, 2023 12:59pm
Antiviral
When can we expect the results?
(38)
•••
Turtle4
X
View Profile
View Bullboard History
Post by
Turtle4
on Sep 12, 2023 11:04am
Takeover?
The share price is again below 10 cents. All we can hope for is a takeover at 20 cents. That makes a market cap of almost 50 million CAD. Of course this is frustrating and the share price has been
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Sep 11, 2023 1:56pm
RE:RE:RE:RE:Skinmedica - Even & Correct Dark Spot Cream
At 9 cents, its trading like it certainly is a joke. But if/when they execute, this will likely not be a joke and very different than the R&F bs.
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Sep 11, 2023 12:01pm
RE:RE:RE:Skinmedica - Even & Correct Dark Spot Cream
Why do I get the feeling we are being mislead, yet again? Is this another R&F joke?
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >